About OAE
Introduction of OAE

OAE Publishing Inc. (OAE) is a non-profit, online, open-access publisher specializing in biomedical peer-reviewed journals. With the goals of promoting academic exchange and knowledge sharing, OAE set up a free academic platform for biomedical experts and scholars all over the world. Featuring with standard publication ethics, a rigorous peer review process, and rapid and free publication (no OAE journals charge for submission, processing, or publication), OAE facilitates easier academic exchange without sacrificing quality. All OAE journals strictly comply with the uniform requirements for manuscripts proposed by the International Committee of Medical Journal Editors. The reviewers, editorial board members, Associate Editors, and Editors-in-Chief of each journal are responsible for publication quality.

OAE was founded by Mr. Vincent Fan in 2015. We have offices in California (USA) and Xi’an (China).

US address: 23555 Golden Springs Drive #K-2, Diamond Bar, Los Angeles, CA 91765.

China address: Suite 1705, Plaza B, Green SOHO Alliance, No. 1 Jinye Road, Hi-Tech Development Zone, Xi’an 710065, Shaanxi, China.

Open access

OAE provides open-access publication to offer easy and free access. All users are free to read, download, cite, print, and distribute published manuscripts. This model really facilitates global academic promotion and communication. Importantly, it reaches the widest possible audience and connects researchers to the newest ideas in their fields.

Creative Commons plays an important role in sharing knowledge and creativity to build a more equitable, accessible, and innovative world. The license unlocks the full potential of the Internet to drive a new era of development, growth, and productivity. All OAE journals adopt Creative Common Licenses. There are two kinds of licenses in OAE journals. The Attribution-NonCommercial-ShareAlike 3.0 License allows others to remix, modify, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. The Creative Commons Attribution 4.0 License grants users the right to unrestricted dissemination and re-use of the work, with the one condition that proper attribution is given to authors.

OAE Members

Key management team members:

Publishing credentials

Mr. Vincent Fan has been involved in academic publication for 15 years. He has considerable experience with open access publishing, team management, and internet operations.

Mr. Kevin Liu established the Chinese Journal of Lung Cancer (indexed in Medline) and Thoracic Cancer (IF = 0.799). He is knowledgeable about international journal publishing standards and processes and has rich journal publication experience.

Professor Chang-Tai Xu has been involved in academic publication and editing for more than 20 years. He established and/or assisted with the launches of more than 10 Chinese and English medical journals. He is experienced in academic publication, editing, and team management.

OAE Journals
OAE Publishing Inc. now owns four academic journals:
Plastic and Aesthetic Research has significantly influenced the field of cosmetic surgery since its first publication in June 2014. The journal is now indexed by the Directory of Open Access Journals (DOAJ), DRJI, EBSCO, Eurasian Scientific Journal Index, Google Scholar, Hinari, JournalGuide, JournalTOCs, Open J-Gate, Root Indexing, SHERPA/RoMEO and Wanfang Data.
Neuroimmunology and Neuroinflammation, established in June 2014, is a high-quality academic journal focused on publishing epidemiologic investigations and consensus guidelines and standards in the Asia-Pacific region. The journal is now indexed by CAS, DOAJ, DRJI, EBSCO, Eurasian Scientific Journal Index, Google Scholar, Hinari, JournalGuide, JournalTOCs, Open J-Gate, Root Indexing, SHERPA/RoMEO and Wanfang Data.
Hepatoma Research, established in April 2015, focuses on liver cancer research in the Asia-Pacific region. Geographical representation and discipline specialty are its primary features. The journal is now indexed by DRJI, EBSCO, Eurasian Scientific Journal Index, Google Scholar, JournalGuide, JournalTOCs, Open J-Gate, Root Indexing, SHERPA/RoMEO and Wanfang Data.
Journal of Cancer Metastasis and Treatment, established in April 2015, is devoted to providing in-depth knowledge related to the treatment of cancer metastasis. It aims to provide experts and scholars all over the world with the latest research findings about cancer treatment. Its distinguishing features are its broad coverage and unique content. The journal is now indexed by the Chemical Abstracts Service (CAS) database, DRJI, EBSCO, Eurasian Scientific Journal Index, Google Scholar, JournalGuide, JournalTOCs, Open J-Gate, Root Indexing, SHERPA/RoMEO and Wanfang Data.

These four biomedical journals are published under the management of OAE Publishing Inc. and all rights are reserved by OAE Publishing Inc.
OAE Vision
OAE strives to promote meaningful academic exchange by offering a broad platform to disseminate the latest biochemical research findings and encourage communication between scientists and medical professionals.

OAE Mission
  • Provide a top-ranking academic communication platform that promotes worldwide scientific innovation
  • Provide an open publishing platform for scientific researchers, and cooperate with them to found additional, respected technical journals
  • Establish new journals with a high academic level and rapid publication rate. Expediting free publication allows authors to spread their scientific achievements without worrying about publication rate and fees
  • Provide readers with cutting-edge scientific articles and the latest news, accelerating scientific research communication to support science innovation


OAE Values
Specialization, Focus, Learning, Innovation, Superiority, Responsibility, Loyalty, Integrity, Cooperation, Comprehensiveness, Sharing

Business model
All OAE journals do not charge manuscript publication or advertising fees and currently has no sources of revenue.

Copyright © 2017 OAE Publishing Inc. All Rights Reserved.